Neonatal group B streptococcal disease: From pathogenesis to preventive strategies

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1294-1303

  Melin, P ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Epidemiology; Group B streptococci; Meningitis; Neonatal infection; Prevention; Screening; Sepsis; Streptococcus agalactiae; Vaccine

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; IMMUNOGLOBULIN G; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; POLYSACCHARIDE; STREPTOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIURIA; CHORIOAMNIONITIS; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MICROBIAL SENSITIVITY TEST; MOLECULAR PATHOLOGY; NEWBORN INFECTION; NONHUMAN; ONSET AGE; PATHOGENESIS; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 80051862965     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03576.x     Document Type: Review

References (68)

1. Baker C. Group B streptococcal infections. In: Stevens DL, Kaplan EL, eds, Streptococcal infections. New York, NY: Oxford University Press, 2000; 222-237.
2. Centers for Disease Control. Prevention of perinatal Group B streptococcal disease: a public health perspective. MMWR 1996; 45 (RR-7): 1-24.
3. Schuchat A. Group B streptococcus. Lancet 1999; 353: 51-6.
4. Schrag SJ, Zell ER, Lynsfield R et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233-9.
5. Centers for Disease Control. Prevention of perinatal Group B streptococcal disease: revised guidelines from CDC. MMWR 2002; 51 (RR-11): 1-22.
6. Melin P, Verschraegen G, Mahieu L, Claeys G, De Mol P. Towards a Belgian consensus for prevention of perinatal group B streptococcal disease. Indian J Med Res 2004; 119: 197-200.
7. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations United States 2002-2005. MMWR Morb Mortal Wkly Rep 2007; 56: 701-705.
8. Lopez Sastre JB, Fernández Colomer B, Coto Cotallo GD, Ramos Aparicio A, Grupo de Hospitales Castrillo. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr 2005; 94: 451-7.
9. Kuruvilla KA, Thomas N, Jesudasan MV, Jana AK. Neonatal group B streptococcal bacteraemia in India: ten years' experience. Acta Paediatr 1999; 88: 1031-1032.
10. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS ONE 2011; 6: e17861. doi:.
11. Gray KJ, Bennet SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infection in infants, Malawi. Emerg Infecti Dis 2007; 13: 223-228.
12. Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G et al. High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr 2003; 23: 15-23.
13. Schrag SJ, Zywicki S, Farley MM et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
14. Nizet V, Ferrieri P, Rubens CE. Molecular pathogenesis of group B streptococcal disease in newborns. In: Stevens DL, Kaplan EL, eds, Streptococcal infections. New York: Oxford University Press, 2000; 180-221.
15. Van Dyke MK, Phares CR, Lynfield R et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360: 2626-2636.
16. Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010; 37: 375-392.
17. Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR 2010; 59 (RR-10): 32.
18. Bergeron MG, Menard C et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343: 175-9.
19. Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007; 21: 411-24. Epub 2007 Mar 2.
20. Poyart C, Reglier-Poupet H, Tazi A et al. Invasive Group B streptococcal infections in infants, France. Emerg Infect Dis, 2008; 14: 1647-1649.
21. Skoff TH, Farley MM, Petit S et al. Increasing burden of invasive group B streptococcal disease in non pregnant adults, 1990-2007. CID 2009; 49: 85-92.
22. Superior Health Council. Guidelines from the Belgian Health Council, 2003 (SHC 7721): prevention of perinatal group B streptococcal infections. Brussels, Belgium: Service Public Federal Santé publique, Sécurité de la Chaîne alimentaire et Environnement, 2003 (In English, in French, in Dutch).
23. Dahesh S, Hensler ME, Van Sorge NM et al. Point mutation in the Group B Streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 2008; 52: 2915-2918.
24. Melin P. Table 3N Resistance of Streptococcus agalactiae in Belgium. In: SBIMC-BVIKM ed. The Sanford guide to antimicrobial therapy, 22nd edition of the Belgian/Luxembourg Version 2010-2011. Brussels, Belgium: Société Belge d'Infectiologie et de Microbiologie Clinique - Belgische Vereniging voor Infectiologie en Klinische Microbiologie, 2010: 129.
25. Gherardy G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G et al. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol 2007; 45: 2909-2916.
26. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998; 17: 499-503.
27. Boyer KM, Gotoff SP. Prevention of early-onset neonatal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665-1669.
28. Fluegge K, Siedler A, Heinrich B et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics 2006; 117: e1139-e1145.
29. Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus: maternal and nosocomial sources for infant acquisitions. J Pediatr 1979; 95: 431-436.
30. Phares CR, Lynfield R, Farley MM et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299: 2056-2065.
31. Godambe S, Shah PS, Shah V. Breast milk as a source of late onset neonatal sepsis. Pediatr Infect Dis J 2005; 24: 381-382.
32. Gagneur A, Héry-Arnaud G, Croly-Labourdette S et al. Infected breast milk associated with late-onset and recurrent group B streptococcal infection in neonatal twins: a genetic analysis. Eur J Pediatr 2009; 168: 1155-1158.
33. Trijbels-Smeulders MAJM, Kolee LAA, Adriaanse AH, Kimpen JLL, Gerards LJ. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004; 23: 172-173.
34. Johri AK, Paoletti LC, Glaser P et al. Group B streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006; 4: 932-42.
35. Jordan HT, Farley MM, Craig A et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008; 27: 1057-64.
36. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005; 115: 1240-1246.
37. Bergseng H, Afset JE, Radtke A et al. Molecular and phenotypic characterisation of invasive group B streptococcus strains from infants in Norway 2006-2007. Clin Microbiol Infect 2009; 12: 1182-1185. Research note 1-4.
38. Bedford Russell AR, Breathnach A, Sender P. Confirmed group B streptococcus infection: the tip of the iceberg. Arch Dis Child Fetal Neonatal Ed 2001; 45: 84.
39. Gibson RL, Soderland C, Henderson WR Jr. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun 1995; 63: 271-279.
40. Telford JL, Barocchi MA, Margarit I, Rappuoli R, Grandi G. Pili in Gram-positive pathogens. Nature Rev Microbiol 2006; 4: 509-519.
41. Kreikemeyer B, Gamez G, Margarit I et al. Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci. Int J Med Microbiol 2011; 301: 240-251.
42. McDonald HM, Chambers HM. Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor. Infect Dis Obstet Gynecol 2000; 8: 220-227.
43. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987; 110: 31-36.
44. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753-756.
45. Faxelius G, Bremme K, Kvist-Christensen K, Christensen P, Ringertz S. Neonatal septicemia due to group B streptococci - perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988; 16: 423-430.
46. Adair CE, Kowalsky L, Quon H et al. Risk factors for early-onset group B streptococcal disease in neonates: a population based case-control study. CMAJ 2003; 169: 198-203.
47. Sociedad Española de Obstetricia y Ginecología, Sociedad Española de Neonatología, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, Sociedad Española de Quimioterapia, Sociedad Española de Medicina Familiar y Comunitaria. Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas. Enferm Infecc Microbiol Clin 2003;21:417-23.
48. ANAES. Agence Nationale d'Accréditation et d'Evaluation en Santé. Prévention anténatale du risque infectieux bactérien néonatal précoce. 2001. Available at.
49. Leitlinien der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI), Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI), und Deutsche Gesellschaft für Perinatale Medizin (DGPM). Prophylaxe der Neugeborensepsis - frühe Form - durch Streptokokken der Gruppe B. 2008. Available at:.
50. Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe. Prophylaxe der frühen Neugeborenensepsis durch Streptokokken der Gruppe B. Gynäkol Geburtshilfliche Rundsch 2007; 47:103-104.
51. Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. R Coll Obstet Gynecol Guideline 2003; 36: 1-10.
52. Nederlandse Vereniging voor Obstetrie en Gynaecologie. NVGO. 2008. Preventie Van Neonatale Groep-B-Streptokokkenziekte (Gbs-Ziekte). Versie 2.0. 2008. Available at:.
53. Baker C, Edwards M. Group B streptococcal conjugate vaccines. Arch Dis Child 2003; 88: 375-8.
54. Margarit I, Rinaudo CD, Galeotti CL, Maione D et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009; 199: 108-115.
55. Paoletti LC, Madoff LC, Kasper DL. Surface structures of group B Streptococcus important in human immunity. In: Fischetti VA, Novick RP, Ferretti J, Portony DA, Rood JI, eds, Gram-positive pathogens. Washington, DC: ASM Press, 2000; 137-153.
56. Brodeur BR et al. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun 2000; 68: 5610-5618.
57. Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996; 175: 974-976.
58. Pearlman M. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2002; 100: 1405-1412.
59. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, January 5, 2011.
60. Melin P. Group B Streptococcal disease in the newborn - maternal screening methods and antimicrobial prophylaxis. Eur Obst & Gyn 2008; 3: 58-62.
61. Bergeron MG, Danbing K. New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women. Reprod Medi Rev 2004; 11: I-25.
62. Davies HD et al. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women. Clin Infect Dis 2004; 39: 1129-1135.
63. Daniels J, Gray J, Pattison H et al. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG 2011; 118: 257-265.
64. Haberland CA, Benitz WE, Sanders GD et al. Perinatal screening for Group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002; 110: 471-480.
65. Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol 2000; 96: 141-145.
66. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group B streptococcal disease on the incidence and ecology of early onset neonatal sepsis. Lancet Infect Dis 2003; 3: 201-213.
67. Sutkin G, Krohn MA, Heine RP et al. Antibiotic prophylaxis and non group B streptococcal neonatal sepsis. Obstet Gynecol 2005; 105: 581-586.
68. Tanaka S, Kobayashi K, Songjinda P et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 2009; 56: 80-87.